Up next

Autoplay

Bile Duct Cancer Research from Dana-Farber Cancer Institute

3 Views • 06/16/23
Share
Embed
administrator
administrator
Subscribers
0

New treatment options are greatly needed in Bile Duct Cancer (cholangiocarcinoma). New research led by Dana-Farber's James Cleary, MD, PhD in Cancer Discovery finds FGFR2 deletion may predict clinical benefit to molecularly targeted therapy. Video published April 30, 2021.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay